Log in to save to my catalogue

Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic,...

Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic,...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a4fbb785a980432cbc1cd3da35a7b36b

Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial

About this item

Full title

Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial

Publisher

London, England: SAGE Publications

Journal title

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920974118

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Background:
Many cancer patients who receive chemotherapy experience adverse drug effects. Pharmacogenomics (PGx) has promise to personalize chemotherapy drug dosing to maximize efficacy and safety. Fluoropyrimidines and irinotecan have well-known germline PGx associations. At our institution, we have delivered PGx clinical decision support (CDS...

Alternative Titles

Full title

Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a4fbb785a980432cbc1cd3da35a7b36b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a4fbb785a980432cbc1cd3da35a7b36b

Other Identifiers

ISSN

1758-8359,1758-8340

E-ISSN

1758-8359

DOI

10.1177/1758835920974118

How to access this item